采用氟尿嘧啶缓释植入剂治疗卵巢上皮性癌患者的近期疗效观察  

The short-term effect of the treatment of ovarian epithelial carcinoma by using sustained release implant agent

作　　者：刘静[1] 段承志[1] 

机构地区：[1]泰安市中心医院,山东泰安271000

出　　处：《实用妇科内分泌电子杂志》2015年第4期71-71,74,共2页Electronic Journal of Practical Gynecological Endocrinology

摘　　要：目的分析采用氟尿嘧啶缓释植入剂治疗卵巢上皮性癌的疗效。方法选取我院2012年1月-2013年12月收治的卵巢上皮性癌患者60例作为研究对象,随机分为观察组和对照组,各30例。观察组行氟尿嘧啶缓释植入剂治疗,对照组采用化疗方法治疗,比较两组患者的疗效。结果观察组的复发率明显优于对照组,差异有统计学意义（P〈0.05）。结论针对卵巢上皮性癌患者,采用氟尿嘧啶缓释植入剂治疗,能明显降低卵巢上皮性癌的复发率,值得在临床上推广。Objective To analyze the effect of the treatment of ovarian epithelial carcinoma by using the sustained release implant.Methods From January 2012 to December 2013,60 patients with ovarian epithelial carcinoma were randomly divided into observation group and control group,each of 30 cases.The observation group was treated with the sustained release implant,and the control group was treated by chemotherapy,and the effi cacy of the two patients was compared.Results The recurrence rate of the observation group was signifi cantly better than the control group,the difference was statistically signifi cant（P〈0.05）.Conclusion For ovarian epithelial cancer patients,the use of sustained-release implant therapy,can signifi cantly reduce the recurrence rate of ovarian epithelial cancer,worthy of promotion in clinical.

关 键 词：氟尿嘧啶缓释植入剂 卵巢上皮性癌 疗效观察 

分 类 号：R737.31[医药卫生—肿瘤]